Biotech

All Articles

GSK goes down ph. 2 HPV vaccine over shortage of best-in-class prospective

.GSK has broken up a period 2 human papillomavirus (HPV) injection from its pipeline after making a ...

OS Therapies refiles $6M IPO to finance HER2 drug, preclinical ADCs

.Operating system Therapies are going to detail on the NYSE American stock substitution today throug...

ALX's fizzling CD47 reaction price sends stock spiraling down

.ALX Oncology's stage 2 gastric cancer response rate has actually weakened. After observing its CD47...

Ionis axes eye condition coming from aim ats of Roche-partnered prospect after records let down

.Yet Another of Ionis Pharmaceuticals' crucial midphase readouts has disappointed desires, cuing the...

Biogen's chief executive officer mentioned no dangerous sell 2023. He prepares to become bold

.While Biogen's pharma peers are actually searching for late-stage assets with little danger, CEO Ch...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Biography has been a biotech seeking a pipe after it junked its lead possessions over the fi...

Biogen bows out Denali Alzheimer's collab

.Biogen has restored legal rights to an early Alzheimer's health condition program to Denali Therapi...

Takeda taps brand new mind of US oncology business-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of considerable management hirings, firings a...

Vertex, hammered through AATD once again, falls 2 resources on throw away stack

.Tip's try to address an uncommon genetic ailment has attacked one more drawback. The biotech threw ...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of workers

.Vir Medical's second-quarter revenues report wasn't except significant headlines. The company welco...